Based on research conducted at Sydney University, Abyss Solutions is working on robotics technology to detect damage to in-water infrastructure.

Virolock Technologies was spun out of Penn State to commercialise a portable device that boosts early detection of viral infections.

The Paris-Saclay Seed Fund has participated in a funding round for Damae Medical, which has developed technology to detect skin cancer without the need for biopsies.

The $1.5m UConn Innovation Fund, established in August last year, has made its first three investments, namely Torigen Pharmaceuticals, Bioarray Genetics and Shoreline Biome.

Microdermics, a spinout of UBC, has developed a microneedle that injects medication into the upper skin layer, avoiding blood vessels and nerve tissue.